SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-005698
Filing Date
2019-08-02
Accepted
2019-08-02 16:11:32
Documents
2
Period of Report
2019-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_073019.htm 8-K 26898
2 PRESS RELEASE OF TONIX PHARMACEUTICALS HOLDING CORP., DATED AUGUST 2, 2019 ex99-01.htm EX-99.01 10604
  Complete submission text file 0001387131-19-005698.txt   38826
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 19996112
SIC: 2834 Pharmaceutical Preparations